Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Denali Therapeutics Was Informed By Its Partner Sanofi That The Phase 2 HIMALAYA Study Evaluating SAR443820/DNL788 In Participants With Amyotrophic Lateral Sclerosis Did Not Meet The Primary Endpoint Of Change In Als Functional Rating Scale-Revised - 8K

Author: Benzinga Newsdesk | February 16, 2024 09:07am

Posted In: DNLI SNY